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Objective:  
To evaluate the clinical and cost-effectiveness of combined National Health Service (NHS) 
occupational therapy (OT) and physiotherapy (PT) for Parkinson's disease (PD) versus no therapy. 
Background:  
A Cochrane review found small benefits in motor function following PT in PD, but these did not 
translate into changes in quality of life (QoL). A Cochrane review of OT in PD found only two trials; 
these had inadequate data to reach any conclusions on efficacy. Further larger randomised controlled 
trials are needed. 
Methods:  
PD patients at 38 neurology and geriatric outpatients with limitations in activities of daily living 
(ADL) were eligible to be randomised to PT+OT or no therapy. Therapy incorporated an individual 
assessment and goal setting approach. The primary outcome was instrumental ADL measured using 
the Nottingham Extended Activities of Daily Living (NEADL) scale at 3 months post-randomisation. 
Secondary outcomes were: health-related QoL (Parkinson's disease Questionnaire-39, EuroQoL EQ-
5D), adverse events, and carer QoL (Short Form-12). Outcomes were assessed before randomisation 
and at 3, 9 and 15 months post-randomisation, using t-tests. 
Results:  
762 patients with mild to moderate PD were randomised to receive PT+OT (N=381) or no therapy 
(N=381). Contact time with therapists averaged 4 visits of 55 minutes each over 8 weeks. At 3 
months, there was no difference in NEADL total score or PDQ-39 summary index between groups 
(Table 1). EuroQoL EQ-5D quotient was of borderline significance in favour of therapy. There was 
no difference in carer SF-12 physical component score, but less decline in carer SF-12 mental 
component score in the PT+OT arm. Sub-group analyses found no evidence of trends towards a 
therapy effect according to age, baseline NEADL score or disease severity. 
Summary of Patient and Carer QoL Scores 
Outcome Mean Difference (95% CI) p-value 
NEADL Total Score 0.5 (−0.7 to 1.7) 0.4 
PDQ-39 Summary Index 0.007 (−1.5 to 1.5) 1.0 
EuroQoL EQ-5D −0.03 (−0.07 to −0.002) 0.04 
SF-12: Physical Component Score −0.6 (−2.3 to 1.2) 0.5 
SF-12: Mental Component Score −2.1 (−3.9 to −0.3) 0.02 
Negative differences favour PT+OT arm, positive differences favour no therapy arm  
Conclusions:  
PT+OT as currently practised in the NHS produced no beneficial effects on ADL or QoL in mild to 
moderate PD. Further work is required to: (1) establish whether existing NHS PT+OT is effective in 
more advanced PD and (2) identify, develop and evaluate alternative approaches. Alternative 
approaches could include different intensities as well as techniques or indeed, modes of delivery. 
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